SCHEMBL30937651

SCHEMBL30937651

O=C(O)CN1Cc2c(F)cccc2NC1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 1/20 0.53
▸ MMP13 P45452 1/20 0.53
▸ CDK5 Q00535 1/20 0.40
▸ CDK5R1 Q15078 1/20 0.40
▸ HTT P42858 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ HTR5A P47898 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CYP3A4 P08684 2/20 0.34
▸ TDP1 Q9NUW8 2/20 0.34
▸ RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30937744 0.84 ACE (0.52) ACEMMP13CDK5CDK5R1HTT
SCHEMBL30937524 0.83 ACE (0.44) ACEMMP13ALDH1A1KMT2AKDM4E
SCHEMBL31120591 0.81 ACE (0.45) ACEMMP13ALDH1A1KMT2AKDM4E
SCHEMBL30937732 0.80 ACE (0.44) ACEMMP13ALDH1A1KMT2AKDM4E
SCHEMBL30937681 0.78 ACE (0.42) ACEMMP13HTTALDH1A1KMT2A
SCHEMBL30937679 0.76 BRD4 (0.51) ACEMMP13ALDH1A1KMT2AKDM4E
SCHEMBL30937672 0.76 ACE (0.41) ACEMMP13ALDH1A1KMT2AKDM4E
SCHEMBL30937518 0.74 DPP4 (0.38) ACEMMP13ALDH1A1KMT2AKDM4E
SCHEMBL30937588 0.72 ACE (0.48) ACEMMP13ALDH1A1KMT2AKDM4E
SCHEMBL30937538 0.71 PER2 (0.45) CDK5CDK5R1HTTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594307-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2025-08-06 — — EP disclosed
WO-2024073426-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback